BMY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.09%

Insider Buying (Last 12 Months): $349,655.16

Insider Selling (Last 12 Months): $38,934.00

Bristol-Myers Squibb Insider Trading History Chart

Bristol-Myers Squibb Share Price & Price History

^$58.87

▲ +0.64 (1.10%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Bristol-Myers Squibb Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/4/2024	Phil M Holzer	SVP	Sell	700	$55.62	$38,934.00	11,760
11/1/2024	Samit Hirawat	EVP	Buy	1,830	$54.67	$100,046.10	62,109
12/5/2023	Christopher S. Boerner	CEO	Buy	2,000	$49.78	$99,560.00	82,672
11/28/2023	Christopher S. Boerner	CEO	Buy	3,071	$48.86	$150,049.06	79,384
11/20/2023	Theodore R. Samuels, II	Director	Buy	8,500	$49.81	$423,385.00	35,500
8/24/2023	Ann Powell	EVP	Sell	17,986	$61.25	$1,101,642.50	27,868
8/3/2023	Robert M. Plenge	EVP	Sell	732	$61.14	$44,754.48	6,584
5/3/2023	Rupert Vessey	EVP	Sell	50,385	$67.06	$3,378,818.10	47,751
2/6/2023	Ann Powell	EVP	Sell	11,183	$74.69	$835,258.27	23,043
2/6/2023	Giovanni Caforio	CEO	Sell	240,000	$74.65	$17,916,000.00	236,104
11/9/2022	Ann Powell	EVP	Sell	16,250	$80.45	$1,307,312.50	34,226
11/7/2022	Rupert Vessey	EVP	Sell	45,910	$78.88	$3,621,380.80	57,079
9/20/2022	Giovanni Caforio	CEO	Sell	25,000	$69.71	$1,742,750.00	476,104
9/15/2022	Giovanni Caforio	CEO	Sell	50,000	$71.84	$3,592,000.00	501,104
9/14/2022	Ann Powell	EVP	Sell	25,000	$70.75	$1,768,750.00	50,476
9/13/2022	David V. Elkins	CFO	Sell	133,951	$71.30	$9,550,706.30	100,460
6/13/2022	Giovanni Caforio	CEO	Sell	30,000	$74.04	$2,221,200.00	551,104
6/6/2022	Sandra Leung	EVP	Sell	65,000	$74.89	$4,867,850.00	308,627
3/21/2022	Giovanni Caforio	CEO	Sell	25,000	$71.52	$1,788,000.00
3/16/2022	Rupert Vessey	EVP	Sell	74,559	$69.25	$5,163,210.75
3/14/2022	Christopher S. Boerner	EVP	Sell	29,532	$69.20	$2,043,614.40
3/14/2022	Karen Murphy Santiago	SVP	Sell	6,577	$69.19	$455,062.63
2/24/2022	Giovanni Caforio	CEO	Sell	30,000	$67.00	$2,010,000.00
11/24/2021	Paul von Autenried	EVP	Sell	17,353	$56.92	$987,732.76
11/22/2021	Paul von Autenried	EVP	Sell	18,363	$57.17	$1,049,812.71

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Bristol-Myers Squibb (NYSE:BMY)

76.41% of Bristol-Myers Squibb stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bristol-Myers Squibb Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/22/2024	Stock Yards Bank & Trust Co.	96,315	$4.98M	0.2%	-9.4%	0.005%
11/21/2024	Anchor Investment Management LLC	15,232	$0.79M	0.1%	-2.7%	0.001%
11/21/2024	Tudor Financial Inc.	4,834	$0.25M	0.2%	N/A	0.000%
11/21/2024	Te Ahumairangi Investment Management Ltd	108,947	$5.61M	1.0%	-25.4%	0.005%
11/21/2024	Wealthquest Corp	4,810	$0.25M	0.0%	-21.3%	0.000%
11/20/2024	Bard Financial Services Inc.	40,175	$2.08M	0.2%	-20.7%	0.002%
11/19/2024	M&T Bank Corp	901,347	$46.64M	0.2%	-4.5%	0.044%
11/19/2024	Second Line Capital LLC	5,483	$0.28M	0.1%	N/A	0.000%
11/19/2024	TCW Group Inc.	36,618	$1.90M	0.0%	-1.8%	0.002%
11/19/2024	Hohimer Wealth Management LLC	68,476	$3.54M	0.8%	-1.4%	0.003%
11/18/2024	Soltis Investment Advisors LLC	7,382	$0.38M	0.0%	+8.4%	0.000%
11/18/2024	Rehmann Capital Advisory Group	27,570	$1.44M	0.1%	+9.6%	0.001%
11/18/2024	TD Private Client Wealth LLC	82,008	$4.24M	0.1%	+11.9%	0.004%
11/18/2024	Arete Wealth Advisors LLC	5,499	$0.28M	0.0%	-37.4%	0.000%
11/18/2024	Teachers Retirement System of The State of Kentucky	278,908	$14.43M	0.1%	+70.7%	0.014%
11/18/2024	Sunbelt Securities Inc.	20,116	$1.04M	0.1%	+6.2%	0.001%
11/18/2024	Toronto Dominion Bank	835,084	$43.21M	0.1%	-23.0%	0.041%
11/18/2024	Coldstream Capital Management Inc.	29,133	$1.53M	0.0%	+47.1%	0.001%
11/16/2024	Geode Capital Management LLC	43,204,016	$2.23B	0.2%	+2.5%	2.130%
11/15/2024	Insight Inv LLC	22,196	$1.15M	1.0%	-2.1%	0.001%
11/15/2024	3Chopt Investment Partners LLC	50,279	$2.60M	0.9%	+10.9%	0.002%
11/15/2024	Frisch Financial Group Inc.	4,112	$0.21M	0.1%	N/A	0.000%
11/15/2024	Prestige Wealth Management Group LLC	28,375	$1.47M	0.3%	+25.0%	0.001%
11/15/2024	Vestcor Inc	38,827	$2.01M	0.1%	-46.9%	0.002%
11/15/2024	Resources Management Corp CT ADV	53,707	$2.78M	0.4%	-5.5%	0.003%
11/15/2024	M&T Bank Corp	901,347	$46.64M	0.1%	-4.5%	0.044%
11/15/2024	Abel Hall LLC	17,402	$0.90M	0.6%	+42.0%	0.001%
11/15/2024	Continuum Advisory LLC	1,506	$78K	0.0%	+39.1%	0.000%
11/15/2024	O Brien Greene & Co. Inc	6,048	$0.31M	0.1%	-4.1%	0.000%
11/15/2024	LRI Investments LLC	4,190	$0.22M	0.0%	+58.6%	0.000%
11/15/2024	Harvest Investment Advisors LLC	30,255	$1.57M	1.1%	+3.7%	0.001%
11/15/2024	PYA Waltman Capital LLC	3,925	$0.20M	0.1%	N/A	0.000%
11/15/2024	Geller Advisors LLC	5,976	$0.31M	0.0%	+19.1%	0.000%
11/15/2024	Public Employees Retirement System of Ohio	1,110,095	$57.44M	0.2%	-0.4%	0.055%
11/15/2024	Nomura Asset Management Co. Ltd.	1,284,144	$66.44M	0.2%	+23.4%	0.063%
11/15/2024	Raab & Moskowitz Asset Management LLC	18,483	$0.96M	0.2%	-5.6%	0.001%
11/15/2024	MML Investors Services LLC	313,688	$16.23M	0.1%	+1.5%	0.015%
11/15/2024	Dean Investment Associates LLC	78,796	$4.08M	0.6%	-6.5%	0.004%
11/15/2024	Headinvest LLC	18,347	$0.95M	0.2%	-5.6%	0.001%
11/15/2024	Kimelman & Baird LLC	21,347	$1.10M	0.1%	-4.8%	0.001%
11/15/2024	Dunhill Financial LLC	664	$34K	0.0%	+39.8%	0.000%
11/15/2024	Orion Portfolio Solutions LLC	39,497	$2.04M	0.0%	-0.8%	0.002%
11/15/2024	Zacks Investment Management	4,983	$0.26M	0.0%	-56.4%	0.000%
11/15/2024	Zega Financial LLC	8,382	$0.43M	0.1%	N/A	0.000%
11/15/2024	iSAM Funds UK Ltd	6,469	$0.34M	0.2%	-14.1%	0.000%
11/15/2024	National Bank of Canada FI	2,506,741	$129.70M	0.2%	+194.7%	0.124%
11/15/2024	Hendershot Investments Inc.	5,404	$0.28M	0.0%	+58.1%	0.000%
11/15/2024	iA Global Asset Management Inc.	76,775	$3.97M	0.1%	+81.3%	0.004%
11/15/2024	EP Wealth Advisors LLC	49,252	$2.55M	0.0%	+25.0%	0.002%
11/15/2024	United Services Automobile Association	381,852	$19.76M	0.5%	-32.8%	0.019%
11/15/2024	Insigneo Advisory Services LLC	14,064	$0.73M	0.1%	-32.8%	0.001%
11/15/2024	Kovitz Investment Group Partners LLC	284,461	$13.47M	0.1%	+20.5%	0.014%
11/15/2024	Voya Financial Advisors Inc.	4,052	$0.21M	0.0%	N/A	0.000%
11/15/2024	Wellington Management Group LLP	150,188	$7.77M	0.0%	-9.9%	0.007%
11/15/2024	Worldquant Millennium Advisors LLC	553,656	$28.65M	0.2%	+84.2%	0.027%
11/15/2024	Two Sigma Advisers LP	9,550,500	$494.14M	1.2%	-15.9%	0.471%
11/15/2024	State Street Corp	92,896,580	$4.81B	0.2%	+1.6%	4.580%
11/15/2024	Stevens Capital Management LP	28,492	$1.47M	0.2%	N/A	0.001%
11/15/2024	Stifel Financial Corp	1,991,717	$103.05M	0.1%	+6.4%	0.098%
11/15/2024	SYM FINANCIAL Corp	7,742	$0.40M	0.1%	-6.3%	0.000%
11/15/2024	SageView Advisory Group LLC	4,676	$0.24M	0.0%	-30.2%	0.000%
11/15/2024	Quantinno Capital Management LP	198,804	$10.29M	0.1%	+63.2%	0.010%
11/15/2024	Royal London Asset Management Ltd.	1,548,855	$80.14M	0.2%	+0.8%	0.076%
11/15/2024	Redwood Investment Management LLC	141,233	$7.20M	0.6%	-6.7%	0.007%
11/15/2024	Resurgent Financial Advisors LLC	4,383	$0.23M	0.1%	-27.8%	0.000%
11/15/2024	Penn Mutual Asset Management	4,600	$0.24M	0.5%	N/A	0.000%
11/15/2024	Morse Asset Management Inc	10,000	$0.52M	0.1%	+25.0%	0.000%
11/15/2024	Motley Fool Asset Management LLC	81,584	$4.32M	0.3%	+3.6%	0.004%
11/15/2024	IHT Wealth Management LLC	60,627	$3.16M	0.1%	+7.9%	0.003%
11/15/2024	Integrated Wealth Concepts LLC	54,730	$2.83M	0.0%	-10.5%	0.003%
11/15/2024	Investment Management Corp of Ontario	67,367	$3.49M	0.1%	+49.2%	0.003%
11/15/2024	Itau Unibanco Holding S.A.	1,082	$56K	0.0%	-23.2%	0.000%
11/15/2024	Janus Henderson Group PLC	3,554,758	$183.97M	0.1%	+695.1%	0.175%
11/15/2024	Hilltop Holdings Inc.	37,416	$1.94M	0.1%	+19.0%	0.002%
11/15/2024	Centiva Capital LP	18,091	$0.94M	0.0%	N/A	0.001%
11/15/2024	Chevy Chase Trust Holdings LLC	1,106,036	$57.23M	0.2%	-1.7%	0.055%
11/15/2024	Cinctive Capital Management LP	288,448	$14.92M	0.8%	N/A	0.014%
11/15/2024	Coastwise Capital Group LLC	29,539	$1.53M	1.3%	-17.4%	0.001%
11/15/2024	Community Bank N.A.	225,680	$11.68M	1.5%	+3.4%	0.011%
11/15/2024	Ascent Group LLC	32,242	$1.67M	0.1%	N/A	0.002%
11/15/2024	Beacon Investment Advisory Services Inc.	8,151	$0.42M	0.0%	-15.5%	0.000%
11/15/2024	Benjamin Edwards Inc.	115,235	$5.96M	0.1%	N/A	0.006%
11/15/2024	Aureus Asset Management LLC	4,893	$0.25M	0.0%	N/A	0.000%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	24,176	$1.25M	0.2%	N/A	0.001%
11/15/2024	Kestra Investment Management LLC	3,976	$0.21M	0.0%	N/A	0.000%
11/15/2024	Point72 Hong Kong Ltd	24,312	$1.26M	0.1%	-90.6%	0.001%
11/15/2024	FSA Wealth Management LLC	1,815	$94K	0.0%	N/A	0.000%
11/15/2024	Lavaca Capital LLC	4,545	$0.24M	0.1%	N/A	0.000%
11/15/2024	B&L Asset Management LLC	5,098	$0.26M	0.2%	N/A	0.000%
11/15/2024	Erste Asset Management GmbH	173,374	$8.83M	0.1%	N/A	0.009%
11/15/2024	True Wealth Design LLC	1,260	$65K	0.0%	+296.2%	0.000%
11/14/2024	Bellevue Group AG	36,825	$1.91M	0.0%	N/A	0.002%
11/14/2024	Cobblestone Capital Advisors LLC NY	21,303	$1.10M	0.1%	+1.7%	0.001%
11/14/2024	Tradition Wealth Management LLC	5,060	$0.26M	0.0%	-11.1%	0.000%
11/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	338,232	$17.50M	0.1%	-12.9%	0.017%
11/14/2024	Edgestream Partners L.P.	158,123	$8.18M	0.4%	+842.9%	0.008%
11/14/2024	NCM Capital Management LLC	21,388	$1.11M	0.5%	-0.9%	0.001%
11/14/2024	L.M. Kohn & Company	7,754	$0.40M	0.1%	-3.9%	0.000%
11/14/2024	Point72 Europe London LLP	55,851	$2.89M	0.2%	-29.4%	0.003%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	2,282,297	$118.09M	0.2%	+16.0%	0.113%

Data available starting January 2016

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $58.87

$57.62

$58.92

50 Day Range

MA: $53.66

$49.02

$59.82

52 Week Range

Now: $58.87

$39.35

$61.08

Volume

7,412,808 shs

Average Volume

12,398,418 shs

Market Capitalization

$119.40 billion

P/E Ratio

N/A

Dividend Yield

4.12%

Beta

0.44

Who are the company insiders with the largest holdings of Bristol-Myers Squibb?: Bristol-Myers Squibb's top insider shareholders include:
Giovanni Caforio (CEO)
Christopher S Boerner (CEO)
Samit Hirawat (EVP)
Rupert Vessey (EVP)
Theodore R Samuels II (Director)
Ann Powell (EVP)
Phil M Holzer (SVP)
Robert M Plenge (EVP)
Learn More about top insider investors at Bristol-Myers Squibb.
Who are the major institutional investors of Bristol-Myers Squibb?: Bristol-Myers Squibb's top institutional shareholders include:
State Street Corp — 4.58%
Charles Schwab Investment Management Inc. — 3.01%
FMR LLC — 2.22%
Geode Capital Management LLC — 2.13%
Primecap Management Co. CA — 1.15%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.94%
Learn More about top institutional investors of Bristol-Myers Squibb stock.
Which institutional investors are selling Bristol-Myers Squibb stock?: During the last quarter, BMY stock was sold by these institutional investors:
KBC Group NV
Two Sigma Advisers LP
Victory Capital Management Inc.
M&G PLC
AustralianSuper Pty Ltd
DekaBank Deutsche Girozentrale
abrdn plc
Walleye Capital LLC
Which institutional investors are buying Bristol-Myers Squibb stock?: Within the previous quarter, BMY stock was acquired by institutional investors including:
FMR LLC
Jennison Associates LLC
Janus Henderson Group PLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Charles Schwab Investment Management Inc.
Los Angeles Capital Management LLC
National Bank of Canada FI
State Street Corp
During the last year, these company insiders have bought Bristol-Myers Squibb stock:
Giovanni Caforio (CEO)
Christopher S Boerner (CEO)
Samit Hirawat (EVP)
Learn More investors buying Bristol-Myers Squibb stock.